지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.5
- 수록면
- 115 - 127 (13page)
이용수
초록· 키워드
오류제보하기
Proton Pump Inhibitors are used widely to manage many gastric acid-related conditions such as gastroesophageal disease, gastritis, esophagitis, Barrett’s esophagus, Zollinger-Ellison syndrome, peptic ulcer disease, nonsteroidal anti-inflammatory drug-associated ulcers, and Helicobacter pylori eradication, around the globe. This review article focuses on adverse effects associated with the long-term use of proton pump inhibitors. Various observational studies, clinical trials, and meta-analyses have established the adverse effects associated with the long-term use of proton pump inhibitors including renal disorders (acute interstitial nephritis, acute kidney injury, chronic kidney disease, and end-stage renal disease), cardiovascular risks (major adverse cardiovascular events, myocardial infarction, stent thrombosis, and stroke), fractures, infections (Clostridium difficile infection, community-acquired pneumonia, and Coronavirus disease 2019), micronutrient deficiencies (hypomagnesemia, anemia, vitamin B12 deficiency, hypocalcemia, hypokalemia), hypergastrinemia, cancers (gastric cancer, pancreatic cancer, colorectal cancer, hepatic cancer), hepatic encephalopathy, and dementia. Clinicians including prescribers and pharmacists should be aware of the adverse effects of taking proton pump inhibitors for an extended period of time. In addition, the patients taking proton pump inhibitors for long-term should be monitored for the listed adverse effects. The American Gastroenterological association recommends a few non-pharmacological measures and the use of histamine 2 blockers to lessen gastrointestinal symptoms of gastroesophageal reflex disease and the utilization of proton pump inhibitors treatment if there is a definitive indication. Additionally, the American Gastroenterological association’s Best Practice Advice statements emphasize deprescribing when there is no clear indication for proton pump inhibitors therapy.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Is hypomagnesemia associated with using proton pump inhibitors?
Kidney Research and Clinical Practice
2016 .01
-
Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
Journal of Neurogastroenterology and Motility (JNM)
2021 .10
-
Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?
Gut and Liver
2016 .01
-
Clinicians should be aware of proton pump inhibitor–related changes in the gastric mucosa
Clinical Endoscopy
2024 .01
-
Proton Pump Inhibitor 사용과 위암
Korean Journal of Helicobacter Upper Gastrointestinal Research
2021 .09
-
Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
Gut and Liver
2016 .01
-
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Gut and Liver
2017 .01
-
Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis
Gut and Liver
2017 .01
-
Proton Pump Inhibitor-Related Gastric Mucosal Changes
Gut and Liver
2021 .09
-
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
Journal of Neurogastroenterology and Motility (JNM)
2018 .01
-
양성자펌프억제제는 제균 치료에 영향을 줄 수 있는가?
Korean Journal of Helicobacter Upper Gastrointestinal Research
2020 .01
-
Does Proton Pump Inhibitor Increase the Clostridium difficile Infection Risk in the Treatment and Prophylaxis of Stress Ulcers than Histanime-2 Receptor Antagonist?
Gut and Liver
2017 .01
-
Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: Controversies and Its Clinical Implications
Gut and Liver
2016 .01
-
면역관문억제제 투여 환자의 간기능 이상반응 분석
병원약사회지
2022 .11
-
신장이식 환자에게 위장관계 증상 예방 목적으로 투여하는 Proton Pump Inhibitors (PPIs) 안전성 비교분석
병원약사회지
2020 .01
-
Proton Pump Inhibitors and Helicobacter Pylori-Associated Pathogenesis
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis
Journal of Neurogastroenterology and Motility (JNM)
2016 .01
-
Mornitoring and Identification of Human Astrovirus from Groundwater in Korea Based on Highly Sensitive RT-nested PCR Primer Sets
대한의생명과학회지
2021 .12
-
Comparative Renal Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Individual Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Endocrinology and Metabolism
2021 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0